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L@vendahl, P., Woolliams, J. A. and Sinnett-Smith, P. A. 1991. Response of growth hormone to
various doses of growth hormone releasing factor and thyrotropin releasing hormone administered
separately and in combination to dairy calves. Can. J. Anim. Sci. 7l: 1045-1052. Doses of growth
hormone releasing tactor (GRF) and thyrotropin releasing hormone (TRH) and combinations of these
were administered by intravenous injection to six calves aged 155 * 3 days and weighing 136 + 16 kg.
Iniections were at 09:00. 12:00 and 15:00 h on 4 davs. and doses were 0, 15. 30 and 60 pmol GRF
kg-r and 0,275,550 and 1100 pmol TRH kg-r, *ittt CRp plus TRH at all combinations of these
doses. Response of serum growth hormone (GH) was measured as the mean at 5, 10, 15 and 20 min
following injection (PEAK) and the area under the curve during 0-60 min (AUC). The correlation
between PEAK and AUC was 0.98. The variation in PEAK was related to GH prior to injection and
to PEAK 3 h earlier. Separate multiplicative eff'ects for each secretagogue were fitted, with the effects
related to the logarithm of dose. Doubling the dose increased PEAK by 1.46-fold fbllowing GRF
(P<0.05)and1.25-foldfollowingTRH(P<0.05).Therewasnoevidencethattheresultsforeither
secretagogue were afTected by the presence or absence ofthe other. This multiplicative model provides
a description of the synergy between these secretagogues.
Key words: GH-release, GRF, TRH, calves, dose response
LQvendahl, P., Woolliams, J. A. et Sinnett-Smith, P. A. 1991 . Rdponse de I'hormone de croissance(GD er diverses doses de somatocrinine (GRF) et de thyrolib6rine (TRH) administrdes sdpar6-
ment ou en association i des veaux laitiers. Can. J. Anim. Sci. 71: 1045 1052. Diverses doses, simples
et combindes, de GRF hypothalamique et de TRH ont 6t6 administr6es par voie intraveineuse d six
veaux de 155 + 3 j et pesant 136 + 16 kg. Les injections dtaient faites ir 09:00, 12:00 et 15:00 h
pendant 4 jours de suite, aux doses de 0, 15, 30 et 60 pmol kg ' pour la GRF et de 0, 2'75, 550 et
i 100 pmol kg ' pour la TRH, en plus de toutes les combinaisons de doses des deux hormones. Pour
mesurer Ia r6ponse de I'hormone de croissance (GH), on a pris la moyenne des r6actions d 5, 10, 15
et 20 minutes aprds I'injection (PIC), ainsi que Ia surface comprise sous la courbe de 0 h 60 minutes
(AUC). La corr6lation entre les valeurs PIC et les valeurs AUC 6tait de 0,98. On a 6tabli les relations
entre les variations des valeurs PIC et les valeurs pr6-injection, ainsi que les valeurs PIC de l'injection
pr6c6dente (3 h plus tdt). Les effets multiplicatifs s6par6s des deux s6cr6tagogues ont 6t6 ajustds en
regard du logarithme de la dose. Le doublement de la dose a eu pour effet d'accroitre les valeurs PIC
de 1,46 fois aprbs injection de GRF (P < 0,05) et de 1,25 fois aprbs injection de TRH (P < 0,05).
Rien n'indique que les r6sultats observ6s pour chaque hormone aient 6t6 affect6s par la pr6sence ou
I'absence de I'autre. Ce moddle multiplicatif fournit une description du synergisme des deux
s6cr6tagogues.
Mots cl6s: D6charge de GH, GRF (somatocrinine), TRH (thyrolib6rine), veaux, r6sponse 2r la dose
rPresent address (P.L.):
Can. J. Anim. Sci. 71:
National Institute of Animal Science, Foulum, DK-8830, Tjele, Denmark
1045-1052 (Dec. 1991)
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Growth hormone (GH) has important
regulatory roles during growth, pregnancy
and lactation, but the mechanisms controlling
somatotrophs in the pituitary are poorly under-
stood. The release of GH from the anterior
lobe of the pituitary is promoted by growth
hormone releasing factor (GRF) which in its
native form in cattle is a 44 amino acid oeptide
hormone (Esch er al. 1983; Baiie and
Buonomo 1987). The sequence ofthe bovine
and the human form shows only one amino
acid difference within the first 29 amino acids
(Baile and Buonomo 1987). A syntheric pep-
tide containing these 29 amino acids has a GH-
releasing potency equal to that of the full-
length peptide (Petitclerc et al. 1987).
GH release is also induced in cattle by
thyrotropin releasing hormone (TRH) (Johke
1978). Further, a synergistic effect between
GRF and TRH on GH release has been reoorted
in cultured bovine pituitary cells {lngram anil
Bicknell 1986) and in vivo in lactating cows(Lapierre et al. 1987a,1 and calves lHodare
et al. 1985), although its physiological impor-
tance is unknown. Although this synergy is not
affected by photoperiod, it is not evident if
GRF and TRH are administeied in darkness
(Lapierre et al. 1987b).
Dose-response relationships for GRF have
been demonstrated in calves (Johke et al.
1984; Della-Fera et al. 1986: Enrisht er al.
1987). and only limited information is avail-
able on the dose response to TRH (Johke 1978;
Hedlund et al. 1917). Experiments testing
synergy between GRF and TRH have used
only single doses of each hormone, thus
although the synergistic effect has been estab-
lished, there is no information on the comDara-
tive dose-response relationships of GH reiease
with GRF and TRH in the oresence or absence
of the synergy. This study investigated such
relationships with the long-term objective of
obtaining greater understanding of the mech-
anisms that control the release of GH.
MATERIALS AND METHODS
Treatments and Procedures
ANIl,teLs. Six British Friesian calves, five
females and one male, aged 155 + 3 days and
weighing 136 + 16 kg were penned individually
in a well-ventilated barn with fluorescent tube lights
during expcrimental da1s. The calves consumed
.l 4 kg Ll ' concentrate lg kg-r: barley 749.
soya-bean meal 125, molasses 100, salt and mineral
mixture 26) to appetite. Water and hay were avail-
able ad libitum throughout.
Synthetic human pancreatic growth hormone
releasing tactor fragment (1-29) NH, (peptide
purity > 98%; Bachem, Saffron-Walden, Essex,
United Kingdom) was used (henceforth abbreviated
to GRF) at doses of 0, 15, 30 and 60 pmol kg-r
body weight (denoted Go, G,, G, and G,,
respectively). Thyrotropin releasing hormone
(TRH. Sigma Chemical Company, Poole, Dorset,
United Kingdom) was used at doses of 0, 275, 550
and 1 100 pmol kg -' body weight (denoted T6, T,,
T. and T,, respectively). Treatments of GRF plus
TRH were at all combinations of these doses. GRF
and TRH were dissolved in sterile physiological
saline. Saline was also used as vehicle and placebo
in a volume of 5 mL per intravenous injection.
Twelve of the 16 treatments were allocated to each
of the six animals as shown in Table l.
In the absence of any direct experimental evi-
dence, the decision to give multiple injections to only
a few calves was made because previous studies
with another pituitary releasing hormone (LH-RH)
had shown large variation but with a repeatability
of 0.5 (Land 1981). The treatments were given in
random order with three injections daily, at 09:00,
12:00 and l5:00 h on four consecutive days.
An indwelling jugular cannula was placed in each
animal i day prior to the start of the treatments,
through which all treatrnents were given as bolus injec-
tions, and blood samples were taken. Szur-rples were
taken at 
-1,5, -5,5, 10, 15,20, 30,60,90 and
120 min relative to each injection. The cannulae were
kept patent with sterile Na-citrate (4.5% wt vol-r).
After centrifugation (2000 x g, 4"C, 20 min), serum
was harvested and stored at, 
-20"C until assayed.
Table 1. Allocation of calves to treatments
Calf Treatmentz
I
2
3
I
5
o
(Go, Gr, G,, c3) x
(Go, Gr, G2, c3) x
(Go, Gr, G2, G3) x
(Go, Gr, G2) x
(Go, Gr, Gr) x
(Go, G2, G3) x
(To, Tr, T2)
(To, Tr, Tr)
(To, T2, T3)
(To, Tr. T2, Tr)
(To, Tt, T,, Tr)
(To, Tr, T2, T3)
'(...) x (...) denotes all combinations, e.g., (G6, G1)
v tTu. Tr): tG6T9. GuTr. GrT0. C'T't. Gn. G,. G,
andG.qdenoteGRFat0. l5. l0and60pmol kg 'body
weight. Ts, T,, T2 and Tr denote TRH at 0, 215,550
and ll00 pmol kg rbody weight.
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LOVINDAHL ET AI.. GH
Assay
GH was assayed using a double antibody radio-
immunoassay based on that ofHart et al. 1975 but
modified as follows: recombinant DNA-derived
bovine GH (American Cyanamid Company,
Princeton, NJ) was used for radiolabelling (Iodogen
rnethod, Pierce Chemicals, Cambridge, United
Kingdom) and standards. Antisera used were
guinea-pig anti-bGH and donkey anti-guinea-pig
gammaglobulin bound to cellulose (SAC-CEL,
Irnmuno Diagnostic Systems, Washington, Tyne
and Wear, United Kingdom).
A 0.05 M borate buffer of pH 7.8 containins.0.2%
wt vol -r bovine serum albumin and 0.1% wi vol 
'
Na azide was used. Serum samole. '2sI-bGH antl
first antibody was incubated 24 h'at 4'C. Bound GH
was pre-cipitated with SAC CEL by centrifugation.
and '"1-CH bound deterrnined in a gamma
counter. At the final dilution of I : 40 000 of the
first AB in the tubes, binding in the absence of
unlabelled hormone was39%, and the nonspecific
binding was 5 % . The lowest detectable concentra-
tion of GH was between 0.4 ancl 0.8 ng ml--l
standard. Serial dilution of calf serum with buffer
paralleled the standard curve. Cross-reactivity with
FSH, LH and prolactin was not detectable at con-
centrations up to l0 pg rL 
'. Recovery of known
amounts of GH added to serum was 94% .Inter- and
intra-assay coefficients ofvariation were 13 and 6% ,
respectively (three assays),
Statistical Analyses
The GH concentrations in the single serum samples
were combined into the mean of samples taken at
- 
15 and 
-5 min (PzuOR) and the mean of samples
taken at 5, i0, 15, and 20 min after injection
(PEAK). Also. the area under the curve of GH con-
centration plotted against time during the first
60 min after injection (AUC) was calculated. Trans-
formations to natural logarithms were made to
obtain approximate normality for all three variables.
Linear mixed models were fitted using routines
of GENSTAT (Genstat 5 Commiuee 1987). Treat-
ments effects were modelled in two analyses: first,
a full 4 x 4 factorial (15 d0; and second, a reduced
model excluding nonlinear effects ofthe logarithm
ofdose and their interactions and includins factors
for GRF given or nor (Cr. C:.G.,) rrr rGj: I tJD.
for TRH given or not (T,, T:, T:) or (To), I df)
and their interactions (1 df), linear effects of the
logarithm of dose of GRF in rhe absence of TRH
(1 df) or in its presence (l df) and linear effects
of the logarithm of dose of TRH in the absence
of GRF (l dt) or in its presence (1 dfl. The
between-animal variation was modelled as a
RELEASE IN DAIRY CALVES 1047
blocking factor. Further adjustments were made
for days (3 dt) and time of injection (2 d0. The
effect o1'GH concentration prior to injection was
included as a covariate.
From examining the results of the analyses, two
further efTects required attention. First, despite the
logarithmic transfbrmation, considerable hetero-
geneity in the size of the residual variance was
found. One option considered was further trans-
formation, but this would have removed the simple
interpretation offered by logarithms. Therefore the
heterogeneity was accomodated by application of
restricted maximum likelihood (Patterson and
Thompson l97l; Davidian and Carroll 1987) and
estimating separate residual variances for each of
the four subsets of data (Ge,T6), (G0) x (Tr, T2,
T:), (Gr, Gr, G,) x (To) and (Gr, Gz, G3) x (Tr,
T:' T:).
Analyses also revealed that carry-over etfects
were apparent between injections 3 h apart. The
validity of the results therefbre required that these
be adequately modelled. Examination of the
residuals showed a strong negative, linear relation-
ship between the residual error and the response
obtained 3 h previously (Fig. 1). Therefore the
effect was modelled by including the deviation fiom
the mean of the previous response as a covariate.
For injections at time 09:00 h this covariate was
made equal to zero.
RESULTS
An indication of the time course of GH con-
centration iollowing intravenous injections is
shown in Fig. 2 for the average of the treat-
ments for placebo (Go) x (T0), GRF alone
(Gr, Gz, G3) x (T0), TRH alone (G0) x (Tr,
Tz, T:) and GRF plus TRH (G1, G2, G3) x(Tt, Tz, Tr). Peak response was observed
within 15 min and then declined towards pre-
injection concentrations rapidly before 60 min
and then more slowly in the next 60 min. The
correlation between PEAK over the first
20 min and AUC was high (r : 0.98; 70 df;
P < 0.001), and results will be presented
only for PEAK.
The estimated means for each of the 16 treat-
ments after adjustment for the effects described
previously are shown in Fig. 3. The difference
between the full and reduced models for treat-
ments (see Statistical Analyses) was tested by
a likelihood test and was found not to be sig-
nificant (P > 0.1), i.e., the infbrmation con-
tained by the data was adequately described by
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Fig. l. The effect of rnagnitude of response 3 h previously on the response following administration
of GRF, TRH or GRF plus TRH. (o, TRH alone; o, GRF alone; a, GRF plus TRH).
the reduced model, involving regressions on
the logarithm of doses of each secretagogue.
Using the reduced model, there was no
evidence that dose-response relationships for
either TRH or GRF differed according to
whether each secretagogue was given
separately or combined with the other, but the
variation associated with administering GRF
alone made this dose response the least clear
(see Fig. 3). The pooled dose responses were
significant for both TRH and GRF over the
ranges considered. with mean concentration
increasing 1.25-fold (P < 0.05) for a
doubling of the dose of TRH and 1.46-fold
(P < 0.01) for a doubling of the dose of GRF.
For GRF alone the lowest dose of 15 omol
kg -r body weight was sufficient to give a
detectable response (i..e, significantly greater
than saline, with P < 0.05) compared with
550 pmol kg-r body wcight in TRH alone.
Since, on the logarithmic scale of anaiysis,
the responses were linearly related to the
logarithm of dose (interaction terms over and
above the reduced model were not signifi-
cant), it is possible to obtain further informa-
tion on the relationship between the secreta-
gogues by comparing the average of the
treatment means for GRF alone (Gl, G2, G3)
x (To), TRH alone (Go) x (Tr, T:, Ti,) and
GRF plus TRH (Gr, Gz, Gr) x (Tr, T2, T3)
with saline (Go, T6). Following injection of
GRF alone PEAK was 4.44-fold greater
(P < 0.001) than that following saline.
Following TRH alone, PEAK was only
1.55-fold greater (P < 0.001). PEAK
following GRF plus TRH was 9.22-fold
greater (P < 0.001) than following saline.
On the scale of analysis there was no evidence
of synergism (P > 0.1), since the multiplica-
tive effect was consistent with the product of
separate contributions from GRF and TRH
(i.e.,9.221(4.44 x | 55) : 1.34, and the
estimate of L34 was not sienificantlv different
from 1).
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Fig. 2. Serum GH response in calves following administration of saline ( a , n : 6 trials), GRF pooled
over doses of 15, 30 and 60 pmol kg- body weight ( o, n : 15 trials), TRH pooled over doses of
2'75,550 and 1100 pmol kg-' body weight (t. n : 15 trials) and combined administration of GRF
and TRH pooled over the same doses (., n : 36 trials). Values are mean * SE.
PRIOR was not affected by any of the
experimental factors. However, PEAK was
associated with PRIOR, and the partial
regression coefficient of PEAK on PRIOR
was 0.78 + 0.18 (P < 0.01). Since this was
on logarithmic scales, it suggests a doubling
of PRIOR would be associated with a
1.]2-fold increase in PEAK. This relationshio
did not differ according to whether GRF. or
TRH or both were administered.
The relationship between response and the
response to a treatment 3 h previously is
shown in Fig. l. The relationship was
modelled by linear regression, with a coeffi-
cient of 
-0.31 + 0.07 (P < 0.01).
Variation unexplained by the between-
animal variation or the fixed effects was large,
and heterogeneity was marked even after
transformation onto the losarithmic scale.
After adjusting for the modeis described. the
residual variances ranked "saline. " treatments
involving "TRH alone," treatments involving
"GRF plus TRH" and treatments involving
"GRF alone." with associated coefficients of
variation on the observed scale of33, 38, 69 and
83 %, respectively. Thus administration of GRF
resulted in greater coefficients ofvariation. This
variation was a major contributor to the difficulty
encountered in establishing a clear dose response
for GRF when administered on its own.
DISCUSSION
To study GH responsiveness in dairy calves
it is necessary to have clear information on
dose-response curves of potentially important
secretagogues such as GRF and TRH, includ-
ing minimum doses, the position of the curve
most sensitive to dose. Further. in the absence
of prior evidence on the physiological impor-
tance of synergy between GRF and TRH,
infbrmation is needed on the two-dimensionaljoint response curve for TRH and GRF.
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This trial has provided information on these
aspects beyond that previously published and
has clearly identified factors important to the
precision of subsequent trials.
The relationship between response and GH
concentration prior to injection for both GRF
and TRH and the increased coefficient of
within-animal variation when GRF was
injected were both important in determining
precision and may both be related to the
synchrony of endogenous GH-pulsing and
exogenous stimuli. Tannenbaum and Ling
(1984) showed in rats that GH response to
GRF was very small during an endogenous
GH trough compared to when GRF was given
during an endogenous GH peak. For both
secretagogues, size of response may depend
in part on the size of the releasable GH pool
in the pituitary, and this would be affected by
the time since the most recent peak. Further,
the response to GRF may also be more
profoundly affected by the endogenous
somatostatin. Thus regression on GH concen-
trations prior to injection gave an improve-
ment in precision. but variation in response
to GRF remained large.
A further factor influencing response, and
hence precision, was found to be the carry-
over effect from injections 3 h previously.
This is despite two studies in calves (Plouzek
et al. 1983; Hodate er al. 1985) which have
used repeated injections at 3-h intervals and
have explicitly reported no such effects and
other studies using slightly longer intervals
(e. g. , Enright et al. I 987) in which carry-over
effects were not described. Nevertheless. the
finding in this trial was clear, and a negative
linear relationship was found between the
magnitudes of responses 3 h apart. Although
it was possible to model the carry-over effect,
longer tirne intervals between injections should
be used to avoid such a problem altogether.
The present trial showed that the threshold
dose for an observablc GH release in calves
was less than 15 pmol GRF kg ' body
weight. Upper bounds to this dose have becn
variously estimated with different fragments
as 6.5 pmol kg-' (GRF(l-40) Dclla-Fera
er al . I 986). 36 pmol kg - ' (GFR( I -44) ,
Moseley et al. 1984). 90 pmol kg I
LOVENDAHL ET AL, GH RELEASE IN DAIRY CALVES 105 I
(cRF(l-40), Enright et al. 1987) and
67 pmol tg I 1Cnn1t -29) and, GRF(1-40),
Petitclerc et al. 1987). The generality ofthese
results relies on the equipotency of fragments
shown by Petitclerc et al. (1987). The result
of this trial places a firm emphasis 
.on the
lowest estimate of 6.5 pmol kg-'. The
variation in response and failure to cope with
heterogeneity of data are probable causes of
the high estimates in some of the studies men-
tioned in which lower doses were deemed not
to have elicited responses.
Dose responsiveness for GRF was observed
bctween l5 and 60 pmol kg r. although the
variation made this difficult to establish, and
taken together with the dose-response studies
mentioned previously, suggests the range of
doses used in this trial contains the most
sensitive region of dose response.
For TRH, the threshold derived from this
trial lies between 215 and 550 pmol kg-l
bodvweisht. Previous estimates were less than
300pmo"l kg I in cows (Johke 1978) and
less ihan 325 pmol kg I in calves (Tucker
and Wettemann 1976). These results are con-
sistent and suggest that the lowest dose used
here is very near to the threshold. Hedlund
et al. (1911) gave TRH to calves at doses
greater than those used here and showed that
compared with GRF the maximal response is
much smaller and that little responsiveness is
observed above 1375 pmol kg '. Thus a
tentative conclusion is that the highest dose
used in this study, I 100 pmol kg ', is close
to the ED5e.
In the regions of the dose-response curve
examined, effects of TRH and GRF appeared
multiplicative and so exhibited little inter-
dependence on a logarithmic scale. There was
no evidence of different regressions of the
logarithm of response on the logarithm of
dose fbr one secretagogue in the presence or
absencc of the other, and the comparison of
treatments with GRF alone. TRH alone and
GRF plus TRH also suggested this. Thus in
the absence of precise mechanisms and
dynarnic equations to describe the interaction.
the synergy rcported on the observed scale
(Hodate ct al. 1985) may be reduced by con-
sidering the effccts on a logarithmic scalc.
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In conclusion, the results, in characterising
more fully the two-dimensional dose-
response surface for TRH and GRF and in
identifying factors influencing the large varia-
tion in response, will allow better design and
more informed interpretation of experiments
to understand the pituitary responsiveness to
GH secretagogues in calves.
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